Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 682 trials across Europe, recruiting first
Study on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid
BulgariaStudy on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
CzechiaStudy on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients
SwedenStudy on Stopping Infliximab, Methotrexate, and Azathioprine in Patients with Sarcoidosis in Remission
FranceStudy on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma
BelgiumStudy on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease
FranceStudy on Guselkumab for Healing in Crohn's Disease Patients
BelgiumStudy of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis
BelgiumStudy of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease
AustriaStudy on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis
AustriaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
